https://ddn.pluspedia.org/w/index.php?action=history&feed=atom&title=MCNS 2026-09-05T00:25:55Z Versionsgeschichte dieser Seite in PlusPedia MediaWiki 1.43.3 https://ddn.pluspedia.org/w/index.php?title=MCNS&diff=41913&oldid=prev 2010-04-10T06:30:49Z

<p>Die Seite wurde neu angelegt: „<a href="/wiki/Datei:Pptpdtjpg1.png" title="Datei:Pptpdtjpg1.png">miniatur|Entstehender Artikel</a> {| class=&quot;wikitable&quot; | | bgcolor=&quot;#dfdfdf&quot; | &#039;&#039;&#039;Siehe auch&#039;&#039;&#039; | align=&quot;left&quot; width=&quot;800&quot; | |- | bgcolor=&quot;#d…“</p> <p><b>Neue Seite</b></p><div>[[Datei:pptpdtjpg1.png|miniatur|Entstehender Artikel]]<br /> {| class=&quot;wikitable&quot; |<br /> | bgcolor=&quot;#dfdfdf&quot; | &#039;&#039;&#039;Siehe auch&#039;&#039;&#039;<br /> | align=&quot;left&quot; width=&quot;800&quot; |<br /> |-<br /> | bgcolor=&quot;#dfdfdf&quot; | &#039;&#039;&#039;Freie Übersichtsartikel&#039;&#039;&#039;<br /> | align=&quot;left&quot; width=&quot;800&quot; |<br /> &lt;ref name=&quot;PMID10868999&quot;&gt;Corticosteroid therapy in nephrotic syndrome: a meta-analysis of randomised controlled trials. Arch Dis Child 83(1):45-51 (2000) PMID 10868999 &lt;/ref&gt;&lt;ref name=&quot;PMID7726612&quot;&gt;Alternative treatment to corticosteroids in steroid sensitive idiopathic nephrotic syndrome. Arch Dis Child 71(6):522-6 (1994) PMID 7726612 &lt;/ref&gt;&lt;ref name=&quot;PMID8129444&quot;&gt;Consensus statement on management and audit potential for steroid responsive nephrotic syndrome. Report of a Workshop by the British Association for Paediatric Nephrology and Research Unit, Royal College of Physicians. Arch Dis Child 70(2):151-7 (1994) PMID 8129444 &lt;/ref&gt;&lt;ref name=&quot;PMID7149757&quot;&gt;Minimal change nephrotic syndrome. Histopathology and steroid-responsiveness. Arch Dis Child 57(11):816-7 (1982) PMID 7149757 &lt;/ref&gt;&lt;ref name=&quot;PMID17699461&quot;&gt;A proposed taxonomy for the podocytopathies: a reassessment of the primary nephrotic diseases. Clin J Am Soc Nephrol 2(3):529-42 (2007) PMID 17699461 &lt;/ref&gt;&lt;ref name=&quot;PMID17699450&quot;&gt;Adult minimal-change disease: clinical characteristics, treatment, and outcomes. Clin J Am Soc Nephrol 2(3):445-53 (2007) PMID 17699450 &lt;/ref&gt;&lt;ref name=&quot;PMID17898235&quot;&gt;A new approach to idiopathic nephrotic syndrome. J Am Soc Nephrol 18(10):2621-2 (2007) PMID 17898235 &lt;/ref&gt;&lt;ref name=&quot;PMID9176855&quot;&gt;Treatment of the idiopathic nephrotic syndrome: regimens and outcomes in children and adults. J Am Soc Nephrol 8(5):824-32 (1997) PMID 9176855 &lt;/ref&gt;&lt;ref name=&quot;PMID1450365&quot;&gt;Treatment of childhood nephrotic syndrome. J Am Soc Nephrol 3(4):889-94 (1992) PMID 1450365 &lt;/ref&gt;&lt;ref name=&quot;PMID11318964&quot;&gt;Immunosuppressive agents in childhood nephrotic syndrome: a meta-analysis of randomized controlled trials. Kidney Int 59(5):1919-27 (2001) PMID 11318964 &lt;/ref&gt;&lt;ref name=&quot;PMID18065825&quot;&gt;Rituximab and nephrotic syndrome: a new therapeutic hope? Nephrol Dial Transplant 23(1):11-7 (2008) PMID 18065825 &lt;/ref&gt;&lt;ref name=&quot;PMID17981884&quot;&gt;Rapid remission of steroid and mycophenolate mofetil (mmf)-resistant minimal change nephrotic syndrome after rituximab therapy. Nephrol Dial Transplant 23(1):377-80 (2008) PMID 17981884 &lt;/ref&gt;&lt;ref name=&quot;PMID12953043&quot;&gt;Secondary minimal change disease. Nephrol Dial Transplant 18 Suppl 6():vi52-8 (2003) PMID 12953043 &lt;/ref&gt;&lt;ref name=&quot;PMID2385079&quot;&gt;Glomerular hypertrophy in minimal change disease predicts subsequent progression to focal glomerular sclerosis. Kidney Int 38(1):115-23 (1990) PMID 2385079 &lt;/ref&gt;<br /> |-<br /> | bgcolor=&quot;#dfdfdf&quot; | &#039;&#039;&#039;Wichtige Übersichtsartikel&#039;&#039;&#039;<br /> | align=&quot;left&quot; width=&quot;800&quot;| <br /> |-<br /> | bgcolor=&quot;#dfdfdf&quot; | &#039;&#039;&#039;Medline Suchterm/ Synonyme&#039;&#039;&#039;<br /> | align=&quot;left&quot; width=&quot;800&quot;| <br /> |-<br /> | bgcolor=&quot;#00dfdf&quot; | &#039;&#039;&#039;Was ist das&#039;&#039;&#039;<br /> | align=&quot;left&quot; width=&quot;800&quot;| <br /> |-<br /> | bgcolor=&quot;#dfdfdf&quot; | &#039;&#039;&#039;Struktur&#039;&#039;&#039;<br /> | align=&quot;left&quot; width=&quot;800&quot;| <br /> |-<br /> | bgcolor=&quot;#dfdfdf&quot; | &#039;&#039;&#039;Physiologie&#039;&#039;&#039;<br /> | align=&quot;left&quot; width=&quot;800&quot;| <br /> |-<br /> | bgcolor=&quot;#dfdfdf&quot; | &#039;&#039;&#039;Knockout&#039;&#039;&#039;<br /> | align=&quot;left&quot; width=&quot;800&quot;| <br /> |-<br /> | bgcolor=&quot;#dfdfdf&quot; | &#039;&#039;&#039;Transgen&#039;&#039;&#039;<br /> | align=&quot;left&quot; width=&quot;800&quot;| <br /> |-<br /> | bgcolor=&quot;#dfdfdf&quot; | &#039;&#039;&#039;Mutation&#039;&#039;&#039;<br /> | align=&quot;left&quot; width=&quot;800&quot;| <br /> |-<br /> | bgcolor=&quot;#dfdfdf&quot; | &#039;&#039;&#039;Polymorphismus&#039;&#039;&#039;<br /> | align=&quot;left&quot; width=&quot;800&quot;| <br /> |-<br /> | bgcolor=&quot;#dfdfdf&quot; | &#039;&#039;&#039;Genexpression&#039;&#039;&#039;<br /> | align=&quot;left&quot; width=&quot;800&quot;| <br /> |-<br /> | bgcolor=&quot;#dfdfdf&quot; | &#039;&#039;&#039;Inhibitoren&#039;&#039;&#039;<br /> | align=&quot;left&quot; width=&quot;800&quot;| <br /> |-<br /> | bgcolor=&quot;#dfdfdf&quot; | &#039;&#039;&#039;Agonisten&#039;&#039;&#039;<br /> | align=&quot;left&quot; width=&quot;800&quot;| <br /> |}<br /> <br /> ----<br /> <br /> == Bibliographie ==<br /> &lt;references /&gt;<br /> <br /> <br /> {{LinkWP_Miniartikel|Txt=MCNS|Link=Minimal-Change-Glomerulonephritis}}</div>

Ossip Groth